Walter Mier

USPTO Granted Patents = 22 (Patent Applications = 16)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 16 (Patent Applications = 35)

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 70(Granted Patents)

Location History:

Dossenheim, DE (2002)
Heidelberg, DE (2002 - 2005)
Bensheim, DE (2015 - 2024)

Company Filing History:

9 out of 60

Ruprecht-karls-universitat Heidelberg

Deutsches Krebsforschungszentrum

patents

4. 2 out of 119

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

Universitat Heidelberg

patents

7. 1 out of 4

Deutsches Krebsforschungzentrum Stiftung Des Offentlichen Rechts

patents

8. 1 out of 1

Ruprecht-Karls-Universität-Heidelberg (Rektorat)

Ruprecht-Karls-universitÄt

patents

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11951190 - Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer (2024-04-09),

2. 11931430 - Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer (2024-03-19),

3. 11401304 - Cyclic NTCP-targeting peptides and their uses as entry inhibitors (2022-08-02),

4. 11202833 - Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levels (2021-12-21),

5. 11045564 - Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer (2021-06-29),

6. 10716757 - Liposomal formulation for the oral hepatic delivery of drugs (2020-07-21),

7. 10703796 - CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases (2020-07-07),

8. 10653796 - Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules (2020-05-19),

9. 10513539 - Hydrophobic modified peptides and their use for liver specific targeting (2019-12-24),

10. 10471160 - Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer (2019-11-12),

11. 10413614 - Conjugates for protection from nephrotoxic active substances (2019-09-17),

12. 10398791 - Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer (2019-09-03),

13. 10363323 - Hydrophobic modified peptides for liver specific diagnosis (2019-07-30),

14. 10253099 - Conjugates of proteins and multivalent cell-penetrating peptides and their uses (2019-04-09),

15. 10065993 - Peptides and peptide/active compound conjugates for renal targeting (2018-09-04),

Title: Walter Mier - Innovative Inventor from Bensheim

Introduction: Walter Mier is a renowned inventor hailing from Bensheim, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Walter Mier holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating solutions for the future.

Career Highlights: With a career spanning over two decades, Walter Mier has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Walter Mier has collaborated with top companies, innovative startups, and brilliant minds in the field, fostering a culture of creativity and innovation.

Conclusion: Walter Mier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the landscape of technological advancements globally.

This text is generated by artificial intelligence and may not be accurate.